<生产厂家价格>

6-(氯甲基)脲嘧啶

6-(氯甲基)脲嘧啶名称

[ CAS 号 ]:
18592-13-7

[ 中文名 ]:
6-(氯甲基)脲嘧啶

[ 英文名 ]:
6-(Chloromethyl)-2,4(1H,3H)-pyrimidinedione

[中文别名 ]:

[英文别名 ]:

6-(chloromethyl)pyrimidine-2,4(1H,3H)-dione
2,4(1H,3H)-Pyrimidinedione, 6-(chloromethyl)-
6-(Chloromethyl)-2,4(1H,3H)-pyrimidinedione
EINECS 242-431-9
6-chloromethylpyrimidine-2,4-dione
6-uracilylmethylchloride
MFCD00466419
6-Chloromethyluracil
6-(Chloromethyl)uracil

6-(氯甲基)脲嘧啶物理化学性质

[ 密度 ]:
1.4±0.1 g/cm3

[ 沸点 ]:
493.9ºC at 760 mmHg

[ 熔点 ]:
257 °C (dec.)(lit.)

[ 分子式 ]:
C₅H₅ClN₂O₂

[ 分子量 ]:
160.558

[ 闪点 ]:
252.5ºC

[ 精确质量 ]:
160.003952

[ PSA ]:
65.72000

[ LogP ]:
0.04

[ 外观性状 ]:
固体;White to Light yellow powder to crystal

[ 蒸汽压 ]:
2.23E-10mmHg at 25°C

[ 折射率 ]:
1.511

[ 储存条件 ]:
室温，密封，干燥

6-(氯甲基)脲嘧啶MSDS

详细MSDS(安全技术说明书)

6-(氯甲基)脲嘧啶安全信息

[ 符号 ]:

GHS07

[ 信号词 ]:
Warning

[ 危害声明 ]:
H315-H319-H335

[ 警示性声明 ]:
P261-P305 + P351 + P338

[ 个人防护装备 ]:
dust mask type N95 (US);Eyeshields;Gloves

[ 危害码 (欧洲) ]:
Xi:Irritant;

[ 风险声明 (欧洲) ]:
R36/37/38

[ 安全声明 (欧洲) ]:
S26-S36

[ 危险品运输编码 ]:
NONH for all modes of transport

[ WGK德国 ]:
3

[ 海关编码 ]:
2933599090

6-(氯甲基)脲嘧啶上下游产品

6-(氯甲基)脲嘧啶上游产品

6-(氯甲基)脲嘧啶下游产品

6-(氯甲基)脲嘧啶海关

[ 海关编码 ]: 2933599090

[ 中文概述 ]:
2933599090. 其他结构上有嘧啶环的化合物(包括其他结构上有哌嗪环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%

[ 申报要素 ]: 品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期

[ Summary ]:
2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

6-(氯甲基)脲嘧啶文献

Synthesis and enzymatic evaluation of pyridinium-substituted uracil derivatives as novel inhibitors of thymidine phosphorylase.

Bioorg. Med. Chem. 10(3) , 525-30, (2002)

A series of water soluble N(1)- and C(6)-substituted uracil pyridinium compounds were prepared as potential inhibitors of thymidine phosphorylase (TP). The C(6)-uracil substituted derivatives were the...

Synthesis and evaluation of 6-methylene-bridged uracil derivatives. Part 1: discovery of novel orally active inhibitors of human thymidine phosphorylase.

Bioorg. Med. Chem. 12(13) , 3431-41, (2004)

A series of novel 6-methylene-bridged uracil derivatives have been prepared as inhibitors of human thymidine phosphorylase (TP). To enhance the in vivo antitumor activity of fluorinated pyrimidine 2'-...

Syntheses of novel heterocycles as anticancer agents.

Bioorg. Med. Chem. 13(10) , 3513-8, (2005)

Several pteridine analogues 4-13, 23-26 have been synthesized and tested in vitro against three cancer cell lines, MCF7 (breast), NCI-H460 (lung) and SF-268 (CNS). All tested pteridines can serve as n...

更多文献